H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, complaint and lot history review, applicable previous investigation(s), sample (if available), labeling, and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a bent needle was confirmed but the exact cause remains unknown.The product returned for evaluation was one 20 g x 0.75 in.Safestep infusion set.The returned product sample was evaluated, and the needle was observed to be bent about 0.8 cm from its base.The following observations were noted during the sample evaluation: the needle was bent at the region where the needle extends from the base.Microscopic examination of the sample found no supporting evidence of a specific root cause.Based on the evidence provided with the returned sample it is unknown when or how the bend occurred in the needle.Damage to the needle could have occurred at the manufacturing facility, during shipping, during use, or during storage of the product; however, no evidence was observed which supported a specific root cause of the event.H3 other text : evaluation findings are in section h.11.
|